11,678 results match your criteria: "Thyroid Follicular Carcinoma"

Objective: Identifying prognostic markers for clinical outcomes is crucial in selecting appropriate treatment options for patients with radioiodine-refractory (RAI-R) differentiated thyroid carcinoma (DTC). The aim of this study was to investigate the prognostic value of clinico-pathological features and semiquantitative [F]FDG PET/CT metabolic parameters in predicting progression-free survival (PFS) in DTC patients with RAI-R.

Patients And Methods: This prospective cohort study included 110 consecutive RAI-R DTC patients who were referred for [F]FDG PET/CT imaging.

View Article and Find Full Text PDF

We report a case of a 60-year-old lady with metastatic follicular thyroid carcinoma (FTC) who was presented with thyrotoxicosis and heart failure symptoms after total thyroidectomy. Clinical features and investigations led to the diagnosis of functional metastatic FTC with concomitant thyrotoxicosis. Levothyroxine therapy was stopped, and she was treated with propylthiouracil (PTU) followed by serial radioiodine treatments (RAITs) with good control of thyrotoxicosis and metastases.

View Article and Find Full Text PDF

Introduction: Thyroid and salivary gland cytopathology frequently present diagnostic challenges due to complex presentations, overlapping features between benign and malignant conditions, particularly with grey-zone entities and rare pathologies. To address these issues, the 45th European Congress of Cytology (ECC) held a slide seminar focused on challenging cases. This article reviews key findings from the six cases discussed, emphasizing the importance of a comprehensive diagnostic approach.

View Article and Find Full Text PDF

Objective: This study aimed to evaluate the intraoperative use of a drain line for smoke suction during robotic thyroidectomy using a gas insufflation one-step single-port transaxillary (GOSTA) approach and its impact on surgical outcomes.

Study Design: Retrospective cohort study.

Setting: University tertiary care facility.

View Article and Find Full Text PDF

Follicular-patterned thyroid neoplasms comprise a diverse group of lesions that pose significant challenges in terms of differential diagnosis based solely on morphologic and genetic features. Thus, the identification of easily testable biomarkers complementing microscopic and genetic analyses is a highly anticipated advancement that could improve diagnostic accuracy, particularly for noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs). These tumors exhibit considerable morphological and molecular heterogeneity, which may complicate their distinction from structurally similar neoplasms, especially when genetic analyses reveal shared genomic alterations (e.

View Article and Find Full Text PDF

Could Be a Promising Marker for Preoperative Diagnosis of High-Grade Papillary Thyroid Carcinoma?

Diagnostics (Basel)

November 2024

Department of the Structure and Function of Chromosomes, Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.

Background/objectives: A modern classification distinguishes between two nosological entities posing an intermediate risk between differentiated and anaplastic carcinoma: poorly differentiated thyroid carcinoma and differentiated high-grade thyroid carcinoma. There are currently few studies searching for the preoperative molecular genetic markers of high-grade papillary thyroid carcinoma (PTC HG), primarily because of a recent WHO reclassification and singling out of a separate entity: high-grade follicular cell-derived nonanaplastic thyroid carcinoma. Therefore, this work was aimed at identifying PTC HG-specific microRNAs and mRNAs that reliably distinguish them from differentiated papillary thyroid carcinoma in preoperative cytology specimens (fine-needle aspiration biopsies).

View Article and Find Full Text PDF

Background: Metastatic follicular thyroid carcinoma to the central nervous system (CNS), including the skull and dura, is exceedingly rare.

Observations: The authors present the case of a gigantic, intraosseous, dural-based follicular thyroid carcinoma, highlighting the operative strategy for this mass. They also provide a literature review of CNS metastases of differentiated thyroid carcinoma.

View Article and Find Full Text PDF

Surgery is the preferred treatment for primary hyperparathyroidism (PHPT), but the presence of MIBI-avid thyroid nodules can complicate the localization of parathyroid adenoma (PA). In this case report, we discuss the role of imaging in localizing PA in a patient with concurrent thyroid nodules. A 49-year-old female presented with hypercalcemia and elevated parathyroid hormone levels.

View Article and Find Full Text PDF

Background: Thyroid cancer is one of the most common endocrine tumors and preoperative diagnosis of thyroid follicular neoplasm (FN) is challenging. Commonly used examination methods have difficulty in distinguishing thyroid cancer from other follicular lesions. At the same time, with the recently released World Health Organization (WHO) guidelines, the risk classification of FNs of the thyroid is a new enlightenment for clinicians in the diagnosis and treatment.

View Article and Find Full Text PDF

Background: Although ultrasound (US) has been widely adopted as the preferred imaging modality for thyroid nodule evaluation, its reliability in distinguishing follicular adenomas from adenocarcinomas based on US features has been a subject of debate. The primary objective of our study was to comprehensively evaluate the efficacy of US-derived intratumoral and peritumoral radiomics in preoperatively differentiating follicular thyroid adenomas from adenocarcinomas, thereby contributing to the ongoing discussion regarding this challenging distinction.

Methods: In total, 195 patients who were pathologically diagnosed with thyroid follicular neoplasm were retrospectively enrolled in this study.

View Article and Find Full Text PDF

Castleman disease is a lymphadenopathy of unknown cause at a single site, which is designated as unicentric Castleman disease, or at multiple sites designated as multicentric Castleman disease. We present a patient who showed axillary reactive lymphoid hyperplasia, likely due to unicentric Castleman disease, and orbital extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) lymphoma in a six-year follow-up. A 76-year-old man had a painless left axillary mass for an unknown period and also left complete blepharoptosis with no other systemic symptoms.

View Article and Find Full Text PDF

[Pancreatic cystic neoplasms: work-up and surveillance].

Praxis (Bern 1994)

November 2024

Abteilung für Gastroenterologie und Hepatologie, Stadtspital Zürich, Zürich

Whereas pancreatic masses are often difficult to detect with transabdominal ultrasound, cross-sectional imaging features high sensitivity for the pancreatic tumors. However, increasing availability of magnetic resonance imaging (MRI) has led to a surge in the detection of benign or precancerous pancreatic lesions. The medical history is characteristic only for two entities.

View Article and Find Full Text PDF

[A Somehow Different Cause of an Upper Gastrointestinal Bleeding].

Praxis (Bern 1994)

November 2024

Medizinische Klinik, Kantonsspital Frauenfeld, Frauenfeld.

We report a case of an 89-year-old patient, who presented with melena and physical degradation at the emergency department. As cause for his symptoms, we found an upper GI-bleeding from a metastasis of a follicular thyroid carcinoma, for which the patient was surgically treated in the year 1996.

View Article and Find Full Text PDF

Presentation and Management of Highly Differentiated Follicular Carcinoma of Ovarian Origin With Gene Variants.

JCEM Case Rep

December 2024

Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

Struma ovarii (SO) is a rare subtype of ovarian teratoma composed of more than 50% thyroid tissue. Extraovarian spread of SO, called peritoneal strumosis, was previously considered benign given the lack of histological malignant features. However, the 2020 World Health Organization Classification of Female Genital Tumors reclassified peritoneal strumosis as highly differentiated follicular carcinoma of ovarian origin (HDFCO), highlighting its low-grade malignant potential.

View Article and Find Full Text PDF

Background: Patients with differentiated thyroid carcinoma have a 10 year survival rate of more than 95%. However, the existence of spinal metastases significantly reduces overall survival. In this study, we review the epidemiology and outcomes of patients with thyroid malignancies with spinal metastases.

View Article and Find Full Text PDF

An Incidental Finding of Concomitant Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Report.

Cureus

November 2024

Department of Internal Medicine, Division of Endocrinology, Ministry of National Guard-Health Affairs, Jeddah, SAU.

Concomitant medullary thyroid carcinoma and papillary thyroid carcinoma in the thyroid gland are rare; however, the incidence is increasing. Here, we present the case of a 77-year-old male who was incidentally found to have thyroid nodules after a road traffic accident. Fine-needle aspiration revealed two inconclusive Bethesda classifications: follicular neoplasm and unsatisfactory.

View Article and Find Full Text PDF
Article Synopsis
  • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, with a generally positive prognosis, but about 10% of patients face mortality due to complications like lymph node metastasis.
  • This study aimed to analyze the expression of the SIX1 protein in two PTC subtypes—classic PTC and follicular variant PTC—and its relationship with clinical outcomes.
  • Results showed that high SIX1 expression correlated with worse clinical features such as larger tumor size, lymph node metastasis, and other aggressive tumor characteristics, indicating it may serve as a marker for poor prognosis in PTC.
View Article and Find Full Text PDF

Disease management of malignant struma ovarii.

Hell J Nucl Med

December 2024

Department of Nuclear Medicine, Qiantang Branch of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Article Synopsis
  • - Malignant struma ovarii (MSO) is a rare type of ovarian goiter that meets criteria for malignant thyroid tumors and can show invasive spread, with serum thyroglobulin (Tg) levels helping to differentiate it from other ovarian cancers.
  • - A case study is presented involving a 54-year-old woman with abdominal pain, diagnosed post-surgery with highly differentiated follicular thyroid carcinoma originating from both ovaries, which had spread to other areas.
  • - After undergoing total thyroidectomy and iodine-131 treatment, her follow-up after one year showed no significant abnormalities, highlighting the need for further discussion on clinical management and monitoring of Tg levels in MSO cases.
View Article and Find Full Text PDF
Article Synopsis
  • High-grade follicular cell-derived non-anaplastic thyroid carcinomas are rare tumors, particularly in patients under 21, and are more commonly diagnosed in older adults.
  • A study focused on 15 patients aged 9-20 revealed various classifications of thyroid carcinoma, including poorly differentiated and differentiated high-grade types, with specific genetic alterations noted, especially in the DICER1 and TP53 genes.
  • Immunohistochemistry tests indicated the presence of BRAF V600E mutations and PTEN alterations, highlighting the molecular complexity of these thyroid cancers in younger populations.
View Article and Find Full Text PDF

Outcome analysis of differentiated thyroid cancer: Experience from tertiary care in Karachi.

Pak J Med Sci

December 2024

Najmul Islam, MBBS, MRCP, FRCP. Professor, Endocrinology Diabetes and Metabolism, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan.

Article Synopsis
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of Immunohistochemistry (IHC) markers (CD56, HBME-1, CK19) in diagnosing malignant thyroid neoplasms, highlighting the challenges of distinguishing between benign and malignant lesions using traditional histopathology.
  • Out of 60 thyroid specimens analyzed, 68.33% were found malignant, with significant loss of CD56 expression in malignant cases and high specificity for CK19 in differentiating follicular neoplasms.
  • The research underscores the importance of incorporating IHC markers to improve diagnostic accuracy for thyroid cancers, particularly in cases of follicular variant papillary thyroid carcinoma and follicular thyroid carcinoma.
View Article and Find Full Text PDF

[Application of 9-gene panel in assisting fine needle aspiration cytology to diagnose thyroid cancer].

Zhonghua Zhong Liu Za Zhi

November 2024

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.

Article Synopsis
  • The study investigates the effectiveness of a 9-gene panel for diagnosing thyroid nodules that have indeterminate cytological results, compared to traditional BRAF V600E single-gene detection.
  • Researchers analyzed 579 thyroid nodule samples from patients, using next-generation sequencing to identify mutations in nine specific genes associated with cancer.
  • The results showed that 47.5% of tested nodules had mutations, with a majority of identified malignant cases linked to the BRAF gene, demonstrating the panel's potential as a diagnostic tool alongside standard cytology methods.
View Article and Find Full Text PDF
Article Synopsis
  • - The case centers on a 67-year-old woman with both papillary and follicular thyroid carcinomas, initially diagnosed with thyrotoxicosis from Graves' disease, presenting with severe metastasis and invasive tumor growth.
  • - Investigation revealed multiple metastases, including intra-cardiac tumor thrombus and bone fractures, leading to a diagnosis of synchronous thyroid cancer types, yet the patient chose palliative care over aggressive treatment options.
  • - The case highlights the challenges in accurately diagnosing synchronous thyroid malignancies and the limitations of the ACR TI-RADS system in detecting certain ultrasonographic features that indicate cancer, especially in patients with Graves' disease.
View Article and Find Full Text PDF